Product Information

NEOMYCIN-POLY-HC EYE DROPS is a generic product labeled by Sandoz Inc., priced at $17.8076 per ML under NDC 61314064175. Its NADAC has been published 625 times since Nov 28, 2013.

FDA first approved this application on May 11, 1988.

NEOMYCIN-POLY-HC EYE DROPS

neomycin sulfate, polymyxin b sulfate and hydrocortisone
$17.8076per ML

Strength

10; 3.5; 10000 mg/mL; mg/mL; [USP'U]/mL

Manufacturer

Sandoz Inc.

NDC

61314064175

Classification

Generic

Dosage Form

SUSPENSION

Route

OPHTHALMIC

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA062874

FDA Approved

5/11/1988

On Market Since

5/9/2003

Pharmacological Classes

Aminoglycoside Antibacterial
Aminoglycosides
Corticosteroid Hormone Receptor Agonists
Corticosteroid
Polymyxin-class Antibacterial
Polymyxins

Price Statistics

The NADAC for NEOMYCIN-POLY-HC EYE DROPS has been published 625 times since Nov 28, 2013, and over the history we have for it it has risen 28.4%. The table below summarizes its recorded NADAC range and movement.

Current price$17.8076 per ML
All-time high$19.1688 (May 13, 2026)
All-time low$13.4327 (Dec 18, 2013)
52-week high$19.1688
52-week low$17.8076
Median price$16.5043
Average price$16.2499
Largest weekly change+15.0% (Jun 19, 2019)
Weeks tracked625
Tracking sinceNov 28, 2013

Price History

1W

-1.6%

1M

-1.6%

3M

-5.5%

6M

-5.0%

1Y

-3.9%

3Y

+7.2%

5Y

+7.7%

All

+28.4%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 79% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 79%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of NEOMYCIN-POLY-HC EYE DROPS?

The current National Average Drug Acquisition Cost (NADAC) for NEOMYCIN-POLY-HC EYE DROPS, manufactured by Sandoz Inc., is $17.8076 per ML (NDC 61314064175), effective Aug 19, 2026.

How has the price of NEOMYCIN-POLY-HC EYE DROPS changed over time?

Over the history we have for it, the NADAC for NEOMYCIN-POLY-HC EYE DROPS has risen 28.4%. It has been tracked across 625 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for NEOMYCIN-POLY-HC EYE DROPS?

Since Nov 28, 2013, the NADAC for NEOMYCIN-POLY-HC EYE DROPS has ranged from a low of $13.4327 (Dec 18, 2013) to a high of $19.1688 (May 13, 2026), with a median of $16.5043 per ML.

Are there cheaper alternatives to NEOMYCIN-POLY-HC EYE DROPS?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NEOMYCIN-POLYMYXIN-HC EAR SUSP, is $3.7894 per ML — about 79% below NEOMYCIN-POLY-HC EYE DROPS.

Who manufactures NEOMYCIN-POLY-HC EYE DROPS?

NEOMYCIN-POLY-HC EYE DROPS (NDC 61314064175) is labeled by Sandoz Inc., and CMS classifies it as a generic product.